News until patents expire—is problematic, he says. It provides an incentive for drug
companies to invest in products to treat lifestyle diseases that primarily affect richer nations …

In today's fast-paced world where Americans crave a quick fix to their medical woes, it takes
more than advice on a healthy lifestyle to satisfy consumers. But along with cutting-edge …

US pharmaceutical patent policy is poised for a major review by the US Supreme Court.
Later this month, the Court will hear a case, Federal Trade Commission (FTC) v. Actavis …

Drug patents are distorted. Unlike most other inventors, drug inventors must complete years
of testing to the government's specifications and seek government approval to …

It is generally recognized that patent law induces continuous investment in medical
advances, and that, in theory, these investments ensure the safe and rapid distribution of …

To give you a perspective on my remarks, I represent an industry association,
Pharmaceutical Research and Manufacturers of America [PhRMA], composed of companies …

Public Health: Access to Drugs in Developing Countries, address the growing complexity of
how issues of intellectual property affect access to medications. These books initially …

Much recent work has trumpeted the so-called problem of the anticommons in the patent
field, especially in connection with medical tools. That conclusion rests on a mistaken …

The push to lower pharmaceutical drug prices has taken a stronger foothold in legislative
and executive actions in recent years. With average prices rising continuously over the past …

This Comment explores the manner in which the Patent and Trademark Office applies the
patentable utility requirement to pharmaceutical inventions and illustrates the difficulties …